|
||
|
Procoagulant Activity in Trauma Patients Provided by: American Society for Clinical Pathology Upon completion of this activity, you will be able to: * describe possible causes and prevention of interference in clot-based activity assays. * discuss setting and clinical laboratory findings in patients with acute coagulopathy of trauma. * describe the major form... |
|
|
Improving VTE Risk Assessment and Prophylaxis in Orthopaedic Surgery Patients Provided by: Med-IQ Course Description: This performance improvement implementation guide is one of several certified educational activities in the complimentary PI CME initiative, Performance Improvement Strategies in VTE Risk Assessment and Prophylaxis. This initiative offers a comprehensiv... |
|
|
Evidence Based Treatment of Heart Failure, Anticoagulation, and Pain Management Provided by: University Learning Systems Session 1 – Wednesday, August 8, 2012 - An Evidence-Based Heart Failure Review Session 2 – Thursday, August 9, 2012 - A Comprehensive, Evidence-Based Review of Anticoagulation Session 3 – Friday, August 10, 2012 - A Comprehensive, Evidenced-Based Revi... |
|
|
Managing the Risks of Anticoagulant Therapy Provided by: Medical Interactive Community Primary care physicians manage many of the patients on long term anticoagulant therapy. They perform a difficult balancing act on a daily basis, weighing each patient’s risk of thromboembolism versus hemorrhage. The preponderance of current medical literature identifies un... |
|
|
Anemia Provided by: The Ohio State University Medical Center Upon completion of this educational activity,the participant will be able to: 1.) Recognize how to classify anemias. 2.) Review the use of the CBC in the initial evaluation of anemia and subsequent appropriate lab tests.... |
|
|
Focus On: Reversal of Anticoagulation Provided by: American College of Emergency Physicians After reading this article, the physician should be able to: * Understand the indications for reversal of warfarin. * Identify the side effects of protamine in heparin reversal. * Recognize the advantages and disadvantages of fresh frozen plasma (FFP) vs. pr... |
|
|
Update on Chronic ITP (Immune Thrombocytopenic Purpura) Provided by: University of California, Davis, Health System Forms CME Credit Application and Disclosure Accreditation The UC Davis Health System is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. This CME activity was planned in accordance... |
|
|
|
Management of Myocardial Infarction Provided by: The Ohio State University Medical Center Description According to National Institutes of Health, most heart attacks are caused by a blood clot that blocks one of the coronary arteries. The coronary arteries bring blood and oxygen to the heart. If the blood flow is blocked, the heart starves for oxygen and heart ce... |
|
|
|
JAK2 Mutations Across a Spectrum of Venous Thrombosis Cases Provided by: American Society for Clinical Pathology Upon completion of this activity, you will be able to: * list the types of thrombi most commonly associated with JAK2 mutations. * outline the best test methods to detect JAK2 mutations. * define the risk for and types of myelodysplastic syndromes that may be associa... |
|
|
Inherited Bleeding Disorders Provided by: CMElectures Dr. Raffini, M.D., is assistant professor of pediatrics -University of Pennsylvania School of Medicine, Philadelphia, PA and attending physician in the division of hematology -Children's Hospital of Philadelphia, Philadelphia, PA. She has completed a two-year National Hemoph... |
|
|
|
Factor V Leiden and Factor V Deficiency: A Tale of Two Disorders. LQCL1008 Provided by: American Society for Clinical Pathology Upon completion of this activity, you will be able to: * discuss the difference between the factor V Leiden and factor V assay tests. * identify the relationships factor V has in the coagulation cascade and explain how factor V Leiden may lead to hypercoagulability. ... |
|
|
Detecting, Managing, and Preventing Pulmonary Embolism Provided by: ANA Continuing Online Education PULMONARY EMBOLISM (PE) occurs when a pulmonary artery becomes blocked-usually by a blood clot that has broken free from its site of origin and embolized or migrated to the lungs. If misdiagnosed, unrecognized, or untreated, PE can cause death quickly-within just an hour. It... |
|
|
Venous Thrombosis Provided by: Harvard Medical School The most common presentations of venous thromboembolism (VTE) are deep vein thrombosis (DVT) of the lower extremity and pulmonary embolism. A risk factor for VTE, either hereditary or acquired, can now be identified in approximately 80 percent of patients. Furthermore, there... |
|
|
|
Improving VTE Risk Assessment and Prophylaxis in Hospitalized Oncology Patients Provided by: Med-IQ Overview: This performance improvement implementation guide is one of several certified educational activities in the complimentary PI CME initiative, Performance Improvement Strategies in VTE Risk Assessment and Prophylaxis. This initiative offers a comprehensive series o... |
|
|
|
Thrombosis in Children Provided by: CMElectures Leslie Raffini, MD, is an assistant professor of pediatrics in the Division of hematology at Children's Hospital of Philadelphia. She is currently completing a National Hemophilia-sponsored fellowship in clinical hemostasis and thrombosis. She has completed a two-year Nation... |
|
|
|
A Novel Thromboelastographic Score to Identify Overt Disseminated Intravascular Coagulation Resulting in a Hypocoagulable State Provided by: American Society for Clinical Pathology Upon completion of this activity, you will be able to: * describe the underlying principle of thromboelastography as a test of hemostasis as well as some of its major limitations. * list the individual components of the International Society on Thrombosis and Haemosta... |
|
|
Surveying the Landscape of Antiplatelet Therapy: Optimizing Outcomes in Atherothrombotic Disease Provided by: Voxmedia International Limitations of clopidogrel therapy for acute coronary syndromes (ACS) have led to the conduct and completion of clinical outcome trials investigating different approaches to reduce ischemic risk. These different approaches include alternative dosing strategies with clopidogr... |
|
|
|
Platelet Count and Prothrombin Time Help Distinguish Thrombotic Thrombocytopenic Purpura-Hemolytic Uremic Syndrome From Disseminated Intravascular Coagulation in Adults Provided by: American Society for Clinical Pathology Upon completion of this activity, you will be able to: * describe how the diagnosis of thrombotic thrombocytopenic purpura (TTP) is complicated by its similarities with other conditions such as disseminated intravascular coagulation. * describe the current understandi... |
|
